Healthcare provider profile · identity verified

Harrison Lee, D.O.

Family Practice · CARSON, CA · NPI 1033439765

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	524	183
Amlodipine Besylate	Amlodipine Besylate	282	102
Lisinopril	Lisinopril	181	62
Omeprazole	Omeprazole	180	60
Rosuvastatin Calcium	Rosuvastatin Calcium	162	58
Losartan Potassium	Losartan Potassium	158	55
Atenolol	Atenolol	133	41
Metformin Hcl	Metformin Hcl	129	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	124	51
Levothyroxine Sodium	Levothyroxine Sodium	120	38
Hydrochlorothiazide	Hydrochlorothiazide	104	36
Albuterol Sulfate Hfa	Albuterol Sulfate	99	56
Gabapentin	Gabapentin	99	36
Metoprolol Tartrate	Metoprolol Tartrate	99	34
Glipizide	Glipizide	98	33
Potassium Chloride	Potassium Chloride	88	32
Tamsulosin Hcl	Tamsulosin Hcl	87	33
Azelastine Hcl	Azelastine Hcl	82	27
Allopurinol	Allopurinol	78	26
Trazodone Hcl	Trazodone Hcl	74	22
Simvastatin	Simvastatin	71	23
Metformin Hcl Er	Metformin Hcl	66	24
Ozempic	Semaglutide	63	11
Pradaxa	Dabigatran Etexilate Mesylate	63	20
Meloxicam	Meloxicam	61	30
Clopidogrel	Clopidogrel Bisulfate	52	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	13
Terazosin Hcl	Terazosin Hcl	44	13
Wixela Inhub	Fluticasone Propion/Salmeterol	42	16
Alendronate Sodium	Alendronate Sodium	41	20
Bisoprolol Fumarate	Bisoprolol Fumarate	40	13
Jardiance	Empagliflozin	39	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	38	13
Furosemide	Furosemide	37	16
Sertraline Hcl	Sertraline Hcl	37	16
Tramadol Hcl	Tramadol Hcl	36	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	11
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Famotidine	Famotidine	33	14
Spironolactone	Spironolactone	33	12
Eliquis	Apixaban	32	11
Triamcinolone Acetonide	Triamcinolone Acetonide	32	17
Ibuprofen	Ibuprofen	31	14
Colchicine	Colchicine	30	12
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Azithromycin	Azithromycin	28	21
Ezetimibe	Ezetimibe	28	suppressed
Finasteride	Finasteride	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Naproxen	Naproxen	26	14
Alprazolam	Alprazolam	25	suppressed
Alvesco	Ciclesonide	25	11
Pantoprazole Sodium	Pantoprazole Sodium	25	suppressed
Carvedilol	Carvedilol	23	suppressed
Lactulose	Lactulose	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	21	21
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Prednisone	Prednisone	21	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	19	19
Estradiol	Estradiol	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	16	11
Lorazepam	Lorazepam	16	suppressed
Glipizide Er	Glipizide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Retin-A	Tretinoin	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Humulin N Kwikpen	Insulin Nph Human Isophane	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error